
Balancing Benefits and Blood Sugar: A Team Approach to PI3K Pathway Inhibitors in HR+/HER2- Metastatic Breast Cancer
Tuesday, December 2, 2025
3:00 p.m. – 4:00 p.m. ET
Please note this TeleECHO program is 3:00 p.m. Eastern, 2:00 p.m. Central, 1:00 p.m. Mountain and 12:00 p.m. Pacific.